Comprehensive Analysis for Histone Acetylation of Human Colon Cancer Cells Treated with a novel HDAC Inhibitor

E-ISSN： 1873-4286|20|11|1866-1873

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.11, 2014-04, pp. : 1866-1873

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells

By Oh Eun-Taex

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

SAHA and curcumin combinations co-enhance histone acetylation in human cancer cells but operate antagonistically in exerting cytotoxic effects

By Zhao Jin-Yan Lu Na Yan Zheng Wang Nan

Journal of Asian Natural Products Research, Vol. 12, Iss. 5, 2010-05 ,pp. : 335-348

Taylor & Francis Ltd

Access to resources Recommend Favorite

Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M Otterson Gregory A

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells

By Kanwar Shailender Yu Yingjie Nautiyal Jyoti Patel Bhaumik Padhye Subhash Sarkar Fazlul Majumdar Adhip

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 827-838

Springer Publishing Company

Access to resources Recommend Favorite

Qualitative and Quantitative Analysis of Histone Acetylation by Mass Spectrometry

Current Pharmaceutical Analysis, Vol. 1, Iss. 3, 2005-11 ,pp. : 319-327

Bentham Science Publishers

Access to resources Recommend Favorite